HLA TYPING DR & DQ LOCI (CLASS II), EDTA BLOOD

image not found

NABL Cap Accredited     
HLA Typing for DR and DQ loci (Class II) identifies specific human leukocyte antigen variants using EDTA blood. This test is critical for organ and bone marrow transplantation, helping match donors and recipients to reduce the risk of rejection. It also supports the assessment of susceptibility to autoimmune disorders and certain genetic conditions. Metropolis Healthcare performs this test using advanced molecular techniques to ensure accurate, high-resolution results for clinical decision-making

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 11,130.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: H0227

Frequently Asked Questions (FAQ's):

What does HLA DR & DQ typing detect?
It identifies specific Class II HLA alleles to help assess compatibility for transplantation and autoimmune risk.

Who should undergo this test?
Patients awaiting organ or bone marrow transplantation and individuals being evaluated for autoimmune disorders.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced molecular HLA typing methods on EDTA blood for high-resolution and reliable results.

What type of sample is required?
An EDTA-anticoagulated blood sample collected via routine venipuncture.

Is fasting required for this test?
No fasting or special preparation is necessary.

What does a positive result indicate?
It identifies specific HLA alleles, aiding in donor-recipient matching and risk assessment for autoimmune conditions.

Can this test guide transplant decisions?
Yes, it plays a crucial role in donor selection and planning immunosuppressive therapy post-transplant.

How soon are results available from Metropolis Healthcare?
Results are typically available within 3–5 working days

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab